Glaukos Corporation (GKOS)
NYSE: GKOS · Real-Time Price · USD
112.92
-1.23 (-1.08%)
At close: Jan 9, 2026, 4:00 PM EST
112.87
-0.05 (-0.04%)
After-hours: Jan 9, 2026, 7:53 PM EST
Glaukos Market Cap
Glaukos has a market cap or net worth of $6.48 billion as of January 9, 2026. Its market cap has decreased by -22.08% in one year.
Market Cap
6.48B
Enterprise Value
6.32B
1-Year Change
-22.08%
Ranking
Category
Stock Price
$112.92
Market Cap Chart
Since June 25, 2015, Glaukos's market cap has increased from $999.60M to $6.48B, an increase of 548.50%. That is a compound annual growth rate of 19.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 8, 2026 | 6.56B | 1.10% |
| Dec 31, 2025 | 6.49B | -21.56% |
| Dec 31, 2024 | 8.27B | 113.12% |
| Dec 29, 2023 | 3.88B | 86.16% |
| Dec 30, 2022 | 2.08B | - |
| Dec 31, 2021 | 2.08B | -38.42% |
| Dec 31, 2020 | 3.38B | 68.22% |
| Dec 31, 2019 | 2.01B | -0.60% |
| Dec 31, 2018 | 2.02B | 128.25% |
| Dec 29, 2017 | 886.60M | -22.95% |
| Dec 30, 2016 | 1.15B | 45.18% |
| Dec 31, 2015 | 792.60M | -20.71% |
| Jun 25, 2015 | 999.60M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 980.11B |
| Johnson & Johnson | 497.74B |
| AbbVie | 397.50B |
| UnitedHealth Group | 313.83B |
| AstraZeneca | 297.23B |
| Merck & Co. | 275.21B |
| Novartis AG | 273.49B |
| Novo Nordisk | 254.60B |